Why the study?
The study aimed to compare the outcomes of pericardiocentesis versus posterior pleura-pericardial window in the treatment of patients with cardiac tamponade.
Does posterior pleural pericardial window reduce recurrent cardiac tamponade and atrial fibrillation compared to pericardiocentesis in patients with cardiac tamponade?
Does posterior pleural pericardial window reduce recurrent cardiac tamponade and atrial fibrillation compared to pericardiocentesis in patients with cardiac tamponade?
Posterior pleural pericardial window is associated with lower rates of recurrent cardiac tamponade and postoperative atrial fibrillation compared to pericardiocentesis.
Answers are grounded in this paper and cite their sources.
May support pericardiocentesis in select tamponade cases; leaves open PPPW role pending randomized confirmation.
Objective: In our study, we aimed to compare the results of patients who underwent pericardiocentesis and posterior pleura-pericardial window in the treatment of cardiac tamponade. Materials and Methods: The results of all patients presenting to our hospitals with cardiac tamponade and who underwent pericardiocentesis and/or posterior pleural pericardial window (PPPW) between January 2010 and May 2021 were compared and analyzed in a retrospective review. They were divided into Group A comprising 37 patients who underwent pericardiocentesis, and Group B comprising 37 patients who underwent PPPW. Results: The mean age was 62.8 ± 7.6 years, with 54.1% males in Group A compared to 59.5 ± 12.3 years and 62.2% males in Group B. The most common etiology in Groups A and B was idiopathic in 24.3% and 16.2%, respectively. Atrial fibrillation occurred in 32.4% versus 10.8% in Groups A and B, respectively ( P < 0.02), and recurrent cardiac tamponade in 24.3% versus 5.4% in Groups A and B, respectively ( P < 0.02). The 30 days' mortality was 5.4% versus 10.8% in Groups A and B, respectively ( P < 0.39). Conclusions: Pericardiocentesis is a safe and effective treatment for cardiac tamponade in select cases; however, PPPW was associated with a lower incidence of postoperative atrial fibrillation and recurrent cardiac tamponade at 6 and 12 months' follow-up, respectively. PPPW appears a more effective treatment option, especially in recurrent pericardial effusion.
No takes yet. Share an insight, caveat, or question.
Er et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: